Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Elastase

EnzymeBest with a meal

Elastase has two completely separate contexts. As an FDA-approved prescription pancreatic enzyme replacement (in pancrelipase products like Creon for cystic fibrosis or chronic pancreatitis), it's standard medical care. As a stand-alone OTC supplement or component of a 'systemic enzyme' blend, human RCT evidence is sparse, mostly older European trials of mixed-enzyme combinations where elastase's individual contribution can't be teased out.

Quick decision guide

May help most

Pancreatic enzyme replacement therapy in people with exocrine pancreatic insufficiency — but those products are prescription, not supplements. As a self-bought 'systemic enzyme' ingredient, no clear best-fit population emerges from the data.

Common dosing range

Prescription PERT is dosed by lipase units (25,000–75,000 with meals). Supplement-grade elastase is usually included in proprietary enzyme blends with no validated stand-alone dose.

When to expect effects

PERT: hours (digestive symptom relief at the next meal). Supplement systemic enzyme blends: weeks claimed for soft-tissue inflammation; evidence weak.

Watch out for

If you actually have exocrine pancreatic insufficiency, you need a prescription pancrelipase product, not a supplement. Self-treating malabsorption with OTC enzymes is inadequate.

Evidence snapshot

Pancreatic enzyme replacement (PERT, prescription)Strong (prescription)
OTC 'digestive enzyme' use (general)Low
Systemic enzyme therapy for soft-tissue inflammation (mixed products)Low
Stand-alone supplemental elastaseLow

What is it

Elastase is a proteolytic (protein-digesting) enzyme that specifically breaks down elastin, a structural protein found in connective tissue, skin, and blood vessel walls. In supplements, it appears as part of digestive enzyme blends.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

Your gastroenterologist has prescribed pancrelipase (Creon, Zenpep, Pancreaze, Pertzye, Viokace) for exocrine pancreatic insufficiency — take the prescription product as directed
You're trialing a multi-enzyme product (containing bromelain, trypsin, chymotrypsin, ± elastase) for post-injury soft-tissue swelling and accept the weak evidence base

Probably skip if…

You think OTC elastase replaces pancrelipase for pancreatic insufficiency — it doesn't, and you'll under-treat
You're hoping a 'systemic enzyme' product will heal an injury significantly faster than ice/elevation/PT
You have allergies to pork (most pancrelipase is porcine) — speak to your prescriber about alternatives
You're using it as a general 'detox' or 'anti-aging' supplement — no evidence supports those uses
You're pregnant or breastfeeding without medical guidance

Evidence at a glance

Exocrine pancreatic insufficiency (PERT, prescription)

Strong Evidence
Effect
Substantially improved fat absorption, stool consistency, weight gain in EPI; quality-of-life improvements documented across CF, chronic pancreatitis, and post-pancreatic-surgery populations
Best fit
People with documented EPI: cystic fibrosis, chronic pancreatitis, pancreatic cancer, post-pancreatic-surgery, severe coeliac disease with pancreatic involvement
Time
Hours (digestive symptoms improve at next meal); weeks to months for weight gain and nutrient repletion

Soft-tissue inflammation / sports injury (systemic enzyme therapy)

Mixed Evidence
Effect
Modest reductions in swelling/pain in older European trials of mixed enzyme products; no isolated elastase data
Best fit
Adults with acute sports injury or post-surgical swelling willing to add a multi-enzyme product on top of standard care
Time
Days to a couple of weeks in trial reports

General 'digestive support' (OTC)

Weak Evidence
Effect
No reliable benefit over placebo in adults without enzyme insufficiency
Best fit
None established
Time
Not established

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Exocrine pancreatic insufficiency (PERT, prescription)

Disease adjunct
Strong Evidence

Pancrelipase — porcine pancreatic enzyme extract containing lipase, amylase, and proteases including elastase activity — is the FDA-approved standard of care for exocrine pancreatic insufficiency (EPI). EPI occurs in cystic fibrosis, chronic pancreatitis, pancreatic cancer, after pancreatic surgery, and sometimes in advanced diabetes or coeliac disease. PERT improves nutrient absorption (especially fat), weight gain, stool quality, and quality of life. Dosing is anchored on lipase units, not elastase units. This is medical care, not 'supplementation' — the appropriate product is prescription pancrelipase, not an OTC enzyme blend.

Effect size
Substantially improved fat absorption, stool consistency, weight gain in EPI; quality-of-life improvements documented across CF, chronic pancreatitis, and post-pancreatic-surgery populations
Time to effect
Hours (digestive symptoms improve at next meal); weeks to months for weight gain and nutrient repletion
Best fit
People with documented EPI: cystic fibrosis, chronic pancreatitis, pancreatic cancer, post-pancreatic-surgery, severe coeliac disease with pancreatic involvement
Less likely
Healthy adults with occasional bloating or mild dyspepsia — these symptoms don't equal EPI and don't justify enzyme replacement

Bottom line: If you have EPI, get a prescription pancrelipase product (Creon, Zenpep, Pancreaze, Pertzye, Viokace). Do not self-treat with OTC enzymes.

SourceWhitcomb et al., 2014 (PERT guidelines) — PubMed — PancreatologyFDA label — pancrelipase (Creon) — U.S. Food and Drug Administration

Soft-tissue inflammation / sports injury (systemic enzyme therapy)

Supplement benefit
Mixed Evidence

Mixed oral enzyme combinations (Wobenzym, Phlogenzym — typically bromelain + trypsin + chymotrypsin + rutoside, sometimes with elastase) have been studied in older European trials for sports injuries, post-surgical edema, and soft-tissue inflammation. Reported effects on swelling and pain are modest. Studies are heterogeneous and elastase-specific contribution can't be isolated. Conservative measures (ice, elevation, NSAIDs, physical therapy) have far stronger evidence per dollar.

Effect size
Modest reductions in swelling/pain in older European trials of mixed enzyme products; no isolated elastase data
Time to effect
Days to a couple of weeks in trial reports
Best fit
Adults with acute sports injury or post-surgical swelling willing to add a multi-enzyme product on top of standard care
Less likely
Anyone expecting a stand-alone elastase product to outperform a multi-enzyme blend

Bottom line: Modest, ingredient-blurred evidence. RICE, NSAIDs, and PT come first.

SourceKlein 2006 — systemic enzyme therapy review — Wiener Medizinische Wochenschrift

General 'digestive support' (OTC)

Supplement benefit
Weak Evidence

OTC digestive enzyme blends marketed for occasional bloating or 'aiding digestion' commonly include elastase alongside protease, lipase, and amylase. Healthy people without pancreatic insufficiency don't need exogenous enzymes — their own pancreas and brush border produce all the enzyme activity needed for ordinary meals. Symptom relief reports are largely subjective and consistent with placebo. If digestive symptoms are persistent, evaluate for SIBO, IBS, coeliac, lactose intolerance, or true EPI rather than mask with enzyme supplements.

Effect size
No reliable benefit over placebo in adults without enzyme insufficiency
Time to effect
Not established
Best fit
None established
Less likely
Anyone with chronic GI symptoms needing diagnostic work-up

Bottom line: Skip in favour of evaluating the underlying cause of symptoms.

SourceKlein 2006 — systemic enzyme therapy review — Wiener Medizinische Wochenschrift

How it works

Pancreatic elastase is one of the body's natural digestive enzymes, produced by the pancreas to break down dietary proteins, particularly elastin. Supplemental elastase, typically derived from microbial fermentation, is added to broad-spectrum enzyme blends to enhance protein digestion. Fecal elastase is also a clinical marker of pancreatic exocrine function - low fecal elastase indicates pancreatic insufficiency. Elastase supplements are not typically used to treat clinical pancreatic insufficiency (prescription pancreatic enzyme replacement is preferred).

How to take it

1. Typical dose
• Prescription PERT (pancrelipase): dosed by lipase units — 25,000–75,000 lipase units with each main meal, 10,000–25,000 with snacks, per gastroenterologist's titration • OTC systemic enzyme blend (mixed): usually 2–6 enteric-coated capsules between meals; elastase-specific dose rarely stated • Stand-alone supplemental elastase: no validated dose
2. Higher studied dose
PERT can exceed 75,000 lipase units/meal in severe insufficiency; pediatric CF dosing is capped at 10,000 lipase units/kg/day (fibrosing colonopathy risk above that). Higher OTC enzyme doses have not been systematically tested.
3. Timing
PERT: with the first bite of each meal/snack containing fat; total daily dose split across all eating events. OTC systemic enzyme products: typically taken between meals (away from food) on the rationale that empty-stomach intake aids absorption into circulation.
4. With food
PERT: yes (with food). Systemic enzyme blends: between meals (empty stomach).
5. Split dosing
PERT: split with every meal. OTC: typically 3 doses/day between meals.
6. How long to try
PERT: indefinite — replaces function the pancreas can't restore. OTC systemic enzyme courses for soft-tissue inflammation are typically run for 2–6 weeks around the event.

What to track

PERT: stool frequency, fat content (steatorrhea), weight, fat-soluble vitamin levels (A, D, E, K)
Soft-tissue indication: swelling, pain, function over 1–3 weeks
Any new abdominal pain or signs of allergic reaction (porcine product)

Bottom line: If you actually need pancreatic enzyme support, see a gastroenterologist for prescription pancrelipase. OTC elastase has weak evidence on its own.

3 commercial forms

Compare the main delivery options and what they’re best suited for.

Prescription pancrelipase (Creon, Zenpep, Pancreaze, Pertzye, Viokace)

Medical-grade

Porcine pancreatic extract containing lipase, amylase, and proteases (which include elastase activity). FDA-approved for exocrine pancreatic insufficiency. Dosed by lipase units. Enteric-coated to survive gastric acid.

Acts in the duodenum; enteric coating critical for activity.

Microbial elastase (Aspergillus / Bacillus origin) — OTC blends

Supplement-grade

Used in OTC 'digestive enzyme' or 'systemic enzyme' formulations. Vegan-suitable. Activity per capsule is rarely disclosed in standardised units. Generally safe but evidence base is weak.

Activity varies by source; stand-alone clinical data are sparse.

Mixed-enzyme 'systemic enzyme' tablets (Wobenzym, Phlogenzym, etc.)

European tradition

Pre-formulated combinations of bromelain, trypsin, chymotrypsin, rutoside, and sometimes elastase, enteric-coated for systemic absorption. The bulk of European 'enzyme therapy' RCT literature uses these combinations; elastase's individual contribution can't be isolated.

Enteric coating allows some intact enzyme absorption into circulation.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

abdominal crampingnauseadiarrhea or constipationperioral irritation (PERT if capsule contents touch lips)

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pancrelipase (prescription PERT) is generally continued in pregnancy when needed — uncontrolled EPI causes maternal and fetal nutritional issues. OTC systemic enzyme blends have not been studied in pregnancy and should be avoided.

SourceFDA label — pancrelipase (Creon) — U.S. Food and Drug Administration

Bottom line: PERT is safe and necessary in EPI. Self-treating malabsorption with OTC enzymes can mask a serious diagnosis.

Interactions

warfarinMinor

Some systemic enzyme products contain bromelain; bromelain may modestly potentiate warfarin's anticoagulant effect. Elastase itself has no established interaction.

acarbose / starch-blockersMinor

PERT contains amylase, which can counteract the action of acarbose taken for diabetes.

SourceFDA label — pancrelipase (Creon) — U.S. Food and Drug Administration
iron supplementsMinor

Pancrelipase may slightly reduce iron absorption; separate by 1–2 hours if both are essential.

SourceFDA label — pancrelipase (Creon) — U.S. Food and Drug Administration

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

If you need pancreatic enzyme replacement: prescription pancrelipase (Creon, Zenpep, Pancreaze, Pertzye, Viokace) — units of lipase clearly stated, enteric-coated micro-spheres
OTC systemic enzyme blends: ingredient list disclosed (no proprietary blends), enteric coating, dose of each component stated in activity units
Third-party tested (USP, NSF, ConsumerLab) for any supplemental enzyme product
Vegan/microbial vs porcine — choose based on dietary restriction; both can have valid activity
If elastase is the listed ingredient on a supplement, look for activity units (e.g. U/g) — not just 'elastase enzyme'

Be skeptical of…

'Replaces Creon' or 'natural alternative to pancrelipase' — OTC enzymes do not match prescription PERT for EPI
'Heals injuries' or 'rebuilds tissue' — systemic enzyme therapy at best reduces transient swelling/pain in mixed-product trials
'Anti-aging' or 'whole-body detox' — no clinical evidence
Combination 'fat-burning enzyme' products — extracellular protease activity does not aid weight loss
Proprietary blends that don't disclose elastase activity in standard units

Frequently asked questions

What does elastase do?⌄

Breaks down the structural protein elastin found in connective tissue. In supplements, it adds to overall protein-digesting capacity.

References by claim

Exocrine pancreatic insufficiency (PERT, prescription)

Whitcomb et al., 2014 (PERT guidelines) — PubMed — Pancreatology (2014) link

FDA label — pancrelipase (Creon) — U.S. Food and Drug Administration (2024) link

Soft-tissue inflammation / sports injury (systemic enzyme therapy)

Klein 2006 — systemic enzyme therapy review — Wiener Medizinische Wochenschrift (2006) link

Other references

Elastase on NIH DSLD — NIH Dietary Supplement Label Database link

Elastase on Wikidata — Wikidata link

Track Elastase with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.